Temporary endovascular balloon occlusion of the bilateral internal iliac arteries for control of hemorrhage during laparoscopic-assisted myomectomy in a nulligravida with a large cervical myoma

2009 ◽  
Vol 91 (3) ◽  
pp. 935.e5-935.e9 ◽  
Author(s):  
Akihiro Takeda ◽  
Kazuyuki Koyama ◽  
Sanae Imoto ◽  
Masahiko Mori ◽  
Kotaro Sakai ◽  
...  
2012 ◽  
Vol 92 (4) ◽  
pp. 386-391 ◽  
Author(s):  
CAROLINE CLAUSEN ◽  
JAKOB STENSBALLE ◽  
CHARLOTTE K. ALBRECHTSEN ◽  
MARC A. HANSEN ◽  
LARS LÖNN ◽  
...  

2021 ◽  
pp. 51-66
Author(s):  
A. E. Markarov ◽  
S. V. Apresyan ◽  
V. I. Dimitrova ◽  
S. A. Papoyan ◽  
D. G. Gromov ◽  
...  

Introduction. In the cohort prospective comparative study, the investigators examined the effectiveness of intraoperative administration of Antiadgesin and adjuvant therapy with Gynestril after laparoscopic-assisted myomectomy combined with temporary balloon occlusion of the internal iliac arteries and embolization of uterine arteries in the treatment of uterine fibroids.Objective. To achieve stable remission of the disease, improve reproductive outcomes after myomectomy.Materials and methods. 100 women who underwent organ-preserving treatment of uterine fibroids from January 1, 2015 to December 31, 2020 were enrolled in the study. The eligibility criteria were as follows: the age of 28–45 years (the mean age was 34 ± 4.5 years), organ-preserving treatment of uterine fibroids. The exclusion criteria from the study were as follows: the age of over 45 years; allergic reactions to mifepristone, Antiadgesin and contrast media; patients with contraindications for use of drugs, with aggravated medical history, with liver diseases, with endometrial hyperplastic processes (adenomyosis, endometrial hyperplasia).Conclusions. It has been shown that the continuous use of Gynestril at a dose of 50 mg/day for 3 months after surgical treatment due to proliferating uterine fibroids led to the absence of disease-recurrences within two years after discontinuation of the drug, and the occurrence of a relapse in one patient three years after treatment. The use of Gynestril after embolization of the uterine arteries made it possible to statistically reduce the size of the node by 25% within 12 months, 50% after 24 months and 70% – after 36 months. (p <0.05). Intraoperative use of Antiadgesin made it possible to prevent adhesion and development of tubalperitoneal infertility.Conclusion. The combination treatment of uterine fibroids, including myomectomy and drug therapy with Antiadgesin and Gynestril, made it possible to implement reproductive function in 73.3% of patients, moreover, 40% of patients had undergone a natural delivery


Sign in / Sign up

Export Citation Format

Share Document